BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston

Kyverna Therapeutics at BPI 2026

Sep 22–25, 2026 Boston, MA ~3k attendees Website

Kyverna Therapeutics takes part in 2 sessions at BPI 2026 in Boston. Its program centres on cell therapies for autoimmune disease and how to manufacture them at scale. One session describes development of next-generation cell therapies for autoimmune disease, and another draws lessons for faster, more affordable ex vivo cell therapy manufacturing.

OrganizationBPI 2026 Attendance
Kyverna Therapeutics
Emeryville, California
Biotech
Clinical-stage biotechnology company developing CAR T-cell therapies for autoimmune diseases.
Panel
Thu Sep 24
9:30am–10:30am
Keynote Panel Discussion: Scaling Cell Therapies- Lessons from Pioneers for Smarter, Faster, and More Affordable Ex Vivo Cell Therapy Manufacturing
Cell Therapy Manufacturing & Analytics · with Iovance Biotherapeutics, Novartis, L7 Informatics
Talk
Fri Sep 25
11:15am–11:35am
Development of Next Generation Cell Therapies for Autoimmune Disease
Development of Emerging Cell & Gene Therapies

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Kyverna Therapeutics

Tell us what you sell and we’ll find the people at Kyverna Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction